Position in TMO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$61,165
-$1,259 QoQ
Shares Held
122
-3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,408
of 2,606 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026REAP Financial Group, LLC holds $186,328 across 3 Diagnostics & Research names. TMO ranks #2 (32.8% of the industry book) .
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,165 | 122 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $62,424 | 127 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $72,431 | 125 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $52,382 | 108 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $42,167 | 104 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $22,392 | 45 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,924 | 21 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $24,742 | 40 | Shares | Sole | 2025-02-27 | |
| 2024-06-30 | $11,060 | 20 | Shares | Sole | 2025-02-27 | |
| 2024-03-31 | $12,786 | 22 | Shares | Sole | 2025-02-27 | |
| 2023-12-31 | $11,146 | 21 | Shares | Sole | 2025-02-27 | |
| No filing history on record for this holder in this stock. | ||||||